ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2023
The Company achieved revenue of $20.7 million during the year ended April 30, 2023, a 6.7% increase from the year ended April 30, 2022. YoY growth increases to 9.0% when adjusting for the effects of currency translation.The Company recorded total revenue of $5.6 million during the three months ended April 30, 2023,...